Rapid, noninvasive detection of diabetes-induced retinal metabolic stress

Archives of Ophthalmology

Volumn 126, Issue 7, 2008, Pages 934-938

  Field, Matthew G ^a   Elner, Victor M ^a,b   Puro, Donald G ^a   Feuerman, Jason M ^a   Musch, David C ^a   Pop Busui, Rodica ^a   Hackel, Richard ^a   Heckenlively, John R ^a   Petty, Howard R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVOPROTEIN;

ADULT; ARTICLE; AUTOFLUORESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; EYE EXAMINATION; HISTOGRAM; HUMAN; IMAGING SYSTEM; METABOLIC STRESS; NON INVASIVE PROCEDURE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINOPATHY;

ADULT; BLOOD GLUCOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; FLAVOPROTEINS; FLUORESCENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS; PHOTIC STIMULATION;

EID: 47549092355     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.7.934     Document Type: Article

References (33)

1. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med. 2003;35(11):1491-1499.
2. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia, VII: effect of long-term administration of antioxidants on the development of retinopathy. Diabetes. 2001;50(8):1938-1942.
3. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97(12):2883-2890.
4. Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005;7(11-12):1581-1587.
5. Kanwar M, Chan PS, Kern TS, Kowluru RA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci. 2007;48(8):3805-3811.
6. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP, Oxidative damage and protection of the RPE, Prog Retin Eye Res. 2000;19(2):205-221.
7. Thompson CB.Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203):1456-1462.
8. Ning X, Baoyu Q, Yuzhen L, Shuli S, Reed E, Li QQ. Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina, Int J Mol Med. 2004;13(1):87-92,
9. Benson RC, Meyer RA, Zaruba ME, McKhann GM, Cellular autofluorescence: is it due to flavins? J Histochem Cytochem. 1979;27(1):44-48,
10. Kindzelskii A, Petty HR, Fluorescence spectroscopic detection of mitochondrial flavoprotein redox oscillations and transient reduction of the NADPH oxidase-associated flavoprotein in leukocytes. Eur Biophys J. 2004;33(4):291-299.
11. Reinert KC, Dunbar RL, Gao W, Chen G, Ebner TJ. Flavoprotein autofluorescence imaging of neuronal activation in the cerebellar cortex in vivo, J Neurophysiol. 2004;92(1):199-211.
12. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C, Diabetes Care. 2007;30(5):1120-1124,
13. Centers for Disease Control and Prevention. National Diabetes Fact Sheet. Atlanta, GA: US Dept of Health and Human Services: 2005.
14. Elner VM, Park S, Cornblath W, Hackel R, Petty HR, Flavoprotein autofluorescence detection of early ocular dysfunction. Arch Ophthalmol. 2008;126(2):259-260.
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183-1197.
16. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: National High Blood Pressure Education Program Coordinating Committee, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290(2):197], JAMA. 2003;289(19):2560-2572.
17. Grundy SM, Cleeman Jl, Daniels SR, et al: American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement [published corrections appear in Circulation. 2005;112(17):e297 and e298]. Circulation. 2005;112(17):2735-2752,
18. Bossuyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem. 2003;49(1):1-6.
19. Bossuyt PM, ReitsmaJB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49(1):7-18.
20. Nathan DM, Singer DE, Hurxthal K, Goodson JD, The clinical information value of the glycosylated hemoglobin assay, N Engl J Med. 1984;310(6):341-346.
21. Singer DE, Coley CM, Samet JH, Nathan DM. Tests of glycemiain diabetes mellitus: their use in establishing a diagnosis and treatment. Ann Intern Med. 1989;110(2):125-137.
22. 10 to improve diabetes management. Clin Diabetes. 2006;24:6-8.
23. Kunz D, Winkler K, Elger CE, Kunz WS. Functional imaging of mitochondrial redox state. Methods Enzymol. 2002;352:135-151.
24. Kunz WS, Kunzetsov AV, Winkler K, Gellerich FN, Neuhof S, Neumann HW, Measurement of fluorescence changes of NAD(P)H and of fluorescent flavoproteins in saponin-skinned human skeletal muscle fibers. Anal Biochem. 1994;216(2):322-327.
25. Schweitzer D, Hammer M, Anders R, DoebbeckeT, Schenke S. Alterations in autofluorescence decay time in the fundus after oxygen provocation [in German], Ophthalmologe. 2004;101(1):66-72.
26. Schweitzer D, Kolb A, Hammer M, Anders R. Time-correlated measurement of autofluorescence: a method to detect metabolic changes in the fundus [in German], Ophthalmologe. 2002;99(10):774-779,
27. Sharifzadeh M, Bernsetin PS, Gellermann W. Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distribution, J Opt Soc Am A Opt Image Sci Vis. 2006;23(10):2373-2387.
28. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW, Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin, J Clin Invest. 1998;102(4):783-791,
29. Abu-EI-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45(8):2760-2766.
30. Podesta F, Romeo G, Liu WH, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol. 2000;156(3):1025-1032.
31. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB, Death of retinal neurons in streptozotocin-induced diabetic mice, Invest Ophthalmol Vis Sci. 2004;45(9):3330-3336.
32. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(2):283-290.
33. Lieth E, GardnerTW, Barber AJ, Antonetti DA; Penn State Retina Research Group, Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol. 2000;28(1):3-8.